Titre :
  • Galectin-1 knockdown increases sensitivity to temozolomide in a B16F10 mouse metastatic melanoma model.
Auteur : Mathieu, Véronique ; Le Mercier, Marie ; De Nève, Nancy ; Sauvage, Sébastien ; Gras, Thierry ; Roland, Isabelle ; Lefranc, Florence ; Kiss, Robert
Informations sur la publication : Journal of investigative dermatology, 127, 10, (page 2399-2410)
Statut de publication : Publié, 2007-10
Sujet CREF : Sciences bio-médicales et agricoles
Mots-clés MeSH : Animals
Antineoplastic Agents -- therapeutic use
Antineoplastic Agents, Alkylating -- pharmacology
Antineoplastic Agents, Alkylating -- therapeutic use
Apoptosis -- drug effects
Cathepsin B -- metabolism
Cell Line, Tumor
Cisplatin -- therapeutic use
Dacarbazine -- analogs & derivatives
Dacarbazine -- pharmacology
Dacarbazine -- therapeutic use
Disease Models, Animal
Female
Galectin 1 -- genetics
Galectin 1 -- physiology
Gene Expression Regulation, Neoplastic -- drug effects
Gene Expression Regulation, Neoplastic -- physiology
HSP72 Heat-Shock Proteins -- physiology
Melanoma -- drug therapy
Melanoma -- pathology
Melanoma -- physiopathology
Mice
Mice, Knockout
RNA, Small Interfering -- pharmacology
Skin Neoplasms -- drug therapy
Skin Neoplasms -- pathology
Skin Neoplasms -- physiopathology
Xenograft Model Antitumor Assays
Note : Comparative Study
Journal Article
Research Support, Non-U.S. Gov't
Langue :
  • Anglais
Identificateurs : urn:issn:0022-202X 
info:doi/10.1038/sj.jid.5700869
info:pii/5700869
info:pmid/17495956